Services-Health Services · SIC 8000

InnovAge Holding Corp.

INNV

Watch

Latest revenue

$251.9M

as of 2026-03-31

Latest net income

$-10.8M

as of 2026-03-31

Net margin

-4.3%

as of 2026-03-31

Price · 5Y

-19.6% / yr 33.4 pts / yr vs S&P 500 66.4% total
Compare:

Live market

delayed ≤15 min
$7.20
2.31%
Market cap
$977.3M
Enterprise value
$977.3M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$10.69
52-wk low
$3.13
Beta
Shares out
135.7M

5-year trend

What this company does

AI

Item 1. BUSINESS Who We Are InnovAge is the leading healthcare delivery platform by number of participants focused on providing all-inclusive, capitated care to high-cost, seniors, many of whom are dual-eligible. Our programs are designed to address two of the most pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of our participant-centered care delivery approach is to improve the quality of care our participants receive, while keeping them in their homes for as long as safely possible and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. Through our Program of All-Inclusive Care for the Elderly…

AI summary unavailable — showing raw filing excerpt

Generated from INNV's filing dated 2025-09-09

Key risks

AI

Table of Contents Item 1A. Risk Factors Our business, results of operations, and financial condition are subject to numerous risks and uncertainties. You should carefully consider the following risk factors before making a decision to invest in our common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, financial condition, operating results and prospects could be materially and adversely affected. You should read these risk factors in conjunction with…

AI summary unavailable — showing raw filing excerpt

Generated from INNV's filing dated 2025-09-09

Profitability

Operating margin

-3.5%

14.9%

Net margin

-3.6%

27.1%

Return on equity

-12.9%

62.8%

Return on assets

-5.8%

47.7%

Leverage

Debt / equity

1.24×

20.1%

Long-term debt / equity

0.24×

7.1%

Debt / assets

55.4%

9.0%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$251.9M+15.5%$-10.8M+4.9%-4.3%

Q4 2025

2025-12-31

$239.7M+14.7%$10.6M+180.3%4.4%

Q3 2025

2025-09-30

$236.1M+15.1%$8.0M+262.7%3.4%

Q2 2025

2025-06-30

$221.4M+11.0%$-785.0K+53.8%-0.4%

Q1 2025

2025-03-31

$218.1M+13.0%$-11.4M-93.3%-5.2%

Q4 2024

2024-12-31

$209.0M+10.6%$-13.2M-283.6%-6.3%

Q3 2024

2024-09-30

$205.1M+12.4%$-4.9M+52.2%-2.4%

Q2 2024

2024-06-30

$199.4M$-1.7M-0.9%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Services-Health Services · SIC 8000

No data yet for industry average

Your notes

Keep private notes on INNV — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$173.3K

Insider selling

$161.7K

Net activity

+$11.6K

Distinct insiders

2

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2025-11-14

Michael Anthony Scarbrough

President and COO

Sale33,000$4.90$161.7K
2025-05-30

Richard C Zoretic

Director

Purchase8,450$4.08$34.5K
2025-05-29

Richard C Zoretic

Director

Purchase14,265$4.04$57.6K
2025-05-28

Richard C Zoretic

Director

Purchase20,000$4.06$81.2K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns INNV

Institutional value

$36.5M

Total shares held

5.0M

Distinct holders

48

-29 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1BlackRock, Inc.1.2M$10.0M-13.8K (-1.1%)Trimmed
2VANGUARD CAPITAL MANAGEMENT LLC877.1K$7.0MNew
3Hillsdale Investment Management Inc.530.0K$4.3MNew
4O'SHAUGHNESSY ASSET MANAGEMENT, LLC272.5K$2.2M+33.7K (+14.1%)Added
5RITHOLTZ WEALTH MANAGEMENT248.1K$2.0M+83.0K (+50.3%)Added
6DIMENSIONAL FUND ADVISORS LP236.5K$1.9M+187.6K (+383.4%)Added
7Nuveen, LLC205.5K$1.6M+162.2K (+375.2%)Added
8Inspire Investing, LLC198.3K$1.6MNew
9VANGUARD FIDUCIARY TRUST CO140.5K$1.1MNew
10VANGUARD PORTFOLIO MANAGEMENT LLC118.6K$951.5KNew
11PRUDENTIAL FINANCIAL INC78.3K$627.8KNew
12Integrated Quantitative Investments LLC67.8K$543.9KNew
13STRS OHIO64.2K$514.9K-33.2K (-34.1%)Trimmed
14JANE STREET GROUP, LLC45.7K$366.3K-45.2K (-49.7%)Trimmed
15Bank of New York Mellon Corp44.1K$353.7K-1.1K (-2.4%)Trimmed
16RHUMBLINE ADVISERS24.2K$193.7K-1.5K (-5.9%)Trimmed
17D'Orazio & Associates, Inc.18.2K$146.0KNew
18Kathmere Capital Management, LLC15.5K$124.6K+2.3K (+17.0%)Added
19UBS Group AG13.0K$104.2K+11.0K (+537.8%)Added
20Baron Wealth Management LLC13.0K$103.9KNew

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once INNV's latest filing finishes processing.